EMA closed 1 November
Submitted by Anonymous (not verified) on 30 October 2024 - 13:00
EMA closed 1 November
Advancing regulatory science research, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 18 November 2024, 13:30 (CET) to 18 November 2024, 17:30 (CET)
Submitted by Anonymous (not verified) on 30 October 2024 - 11:49
Advancing regulatory science research, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 18 November 2024, 13:30 (CET) to 18 November 2024, 17:30 (CET)
List of medicinal products under additional monitoring
Submitted by Anonymous (not verified) on 30 October 2024 - 11:00
List of medicinal products under additional monitoring
List of medicinal products under additional monitoring
Submitted by Anonymous (not verified) on 30 October 2024 - 11:00
List of medicinal products under additional monitoring
Human medicines European public assessment report (EPAR): Gliolan, 5-aminolevulinic acid hydrochloride, Date of authorisation: 07/09/2007, Revision: 10, Status: Authorised
Submitted by Anonymous (not verified) on 30 October 2024 - 9:32
Human medicines European public assessment report (EPAR): Gliolan, 5-aminolevulinic acid hydrochloride, Date of authorisation: 07/09/2007, Revision: 10, Status: Authorised
mHealth data for real world evidence in regulatory decision-making: expert report for HMA-EMA Big Data Steering Group
Submitted by Anonymous (not verified) on 29 October 2024 - 16:16
mHealth data for real world evidence in regulatory decision-making: expert report for HMA-EMA Big Data Steering Group
Human medicines European public assessment report (EPAR): Forxiga, dapagliflozin, Date of authorisation: 11/11/2012, Revision: 32, Status: Authorised
Submitted by Anonymous (not verified) on 29 October 2024 - 16:16
Human medicines European public assessment report (EPAR): Forxiga, dapagliflozin, Date of authorisation: 11/11/2012, Revision: 32, Status: Authorised
Human medicines European public assessment report (EPAR): Edistride, dapagliflozin, Date of authorisation: 09/11/2015, Revision: 25, Status: Authorised
Submitted by Anonymous (not verified) on 29 October 2024 - 15:44
Human medicines European public assessment report (EPAR): Edistride, dapagliflozin, Date of authorisation: 09/11/2015, Revision: 25, Status: Authorised
Scientific Symposium on Advanced Therapy Medicinal Products - ‘Contribution, evolution, revolution’, European Medicines Agency, Amsterdam, the Netherlands, from 10 October 2024, 09:00 (CEST) to 10 October 2024, 17:00 (CEST)
Submitted by Anonymous (not verified) on 29 October 2024 - 15:20
Scientific Symposium on Advanced Therapy Medicinal Products - ‘Contribution, evolution, revolution’, European Medicines Agency, Amsterdam, the Netherlands, from 10 October 2024, 09:00 (CEST) to 10 October 2024, 17:00 (CEST)
PSUSA/00000126/202401
Submitted by Anonymous (not verified) on 29 October 2024 - 15:16
PSUSA/00000126/202401